UK firm plans state-of-the-art precision medicine centre in California

Working with local partners, BIOS Health, of Cambridge, will create a cutting-edge research and clinical trials center for neural digital therapies. The centre will be built around BIOS’s real-time insights into the nervous system,...

Improved radionuclide supply can transform nuclear medicine

Targeted Alpha Therapy (TAT) is a promising cancer treatment in nuclear medicine, but the supply of alpha-emitting radionuclides - which the treatment relies on - is very limited. A lack of alpha-emitting radionuclides in...

Growing microtumours in a dish hailed as ‘rapid way to identify tumour genes’

Researchers have identified a new way to screen genes that cause several different types of cancers to grow, identifying particularly promising targets for precision oncology in oral and esophageal squamous cancers. The study, published in...

Key gene blocks the ‘spillover’ of avian flu to humans

Understanding the genetic make-up of currently circulating avian flu strains may offer one of the best lines of defence against widespread human transmission. This is according to new research which has found a key human...

Depression up, Covid-19 down in disease study list

Depression is now one of the top five most studied disease areas in clinical development, according to new global analysis by Phesi. The mid-year analysis of all this year’s trials to date reveals that Covid-19...

New ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

An extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification.  Pluripotent stem cell technology provider for drug discovery, Axol Bioscience Ltd (Axol), has signed an exclusive agreement...

1 in 6 children ‘neurodivergent’ as autism numbers quadruple

The number of children diagnosed with Attention-deficit /hyperactivity disorder (ADHD), autism and other neurodevelopmental disorders classifying them as ‘neurodivergent’, has rocketed in both the UK and US.  “Now, one in six children in the US...

Antibiotic resistance widespread among bacteria

Genes that make bacteria resistant to antibiotics are much more widespread in our environment than previously known.  A study, from Chalmers University of Technology and the University of Gothenburg in Sweden, shows that bacteria in...

Herpes study sheds light on viral reinfections

A new study on herpes infections of the eye helps shed light on the question of viral reinfections by identifying a key protein involved in viral reinfections that could be targeted by antiviral drugs. University...

An old scientific controversy is resolved… plants do make sounds!

For the first time ever, researchers at Tel Aviv University have recorded and analysed distinct sounds from plants. The click-like sounds, similar to the popping of popcorn, are emitted at a volume similar to human...

How the brain’s ‘internal compass’ works

New study reveals how the brain makes sense of changing environmental cues. Scientists have gained new insights into the part of the brain that gives us a sense of direction, by tracking neural activity with...

Highly targeted ‘light-activated’ cancer treatment on horizon

Scientists at the University of East Anglia are a step closer to creating a new generation of light-activated cancer treatments. The futuristic sounding treatment would work by switching on LED lights embedded close to a...

There’s more to collagen than cosmetics…

Big strides are being made in collagen clinical development, particularly in treatment of age-related conditions. Dr Gen Li, president and founder of Phesi, discusses the increase in collagen research, and its clinical and biological...

Global community will assess environmental impact of clinical trials

The collaborative initiative will publish a publicly available methodology for calculating and comparing the carbon footprint of centralised and decentralised clinical trials. A global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D,...

Pain or gain? How the brain chooses

Imagine having to choose over and over between what you enjoy doing and the pain that it might cause you, whether physical or emotional. If you live with conditions such as depression, anxiety, or chronic...

Precision breeding for a sustainable future: unpacking the future of genomics

Neil Ward, General Manager of PacBio EMEA, examines the potential impact of the UK’s Precision Breeding Bill. Genomic sequencing holds the potential to unlock powerful insights that will advance our understanding of all life. In...